Search Results - "Derchi, Giorgio"
-
1
COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension
Published in Hemoglobin (03-05-2020)“…We here report the successful recovery from coronavirus disease-19 (COVID-19) pneumonia in a patient with β-thalassemia major (β-TM) and severe pulmonary…”
Get full text
Journal Article -
2
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia
Published in Haematologica (Roma) (01-07-2022)Get full text
Journal Article -
3
-
4
Atrial Fibrillation Prevalence and Its Management in Transfusion-Dependent Thalassemias: The Fathal Study
Published in Blood (02-11-2023)“…Atrial fibrillation (AF) represents an emerging issue in the thalassemia population related to increased life expectancy. However, data on AF in these patients…”
Get full text
Journal Article -
5
Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization: A Webthal Study
Published in Circulation (New York, N.Y.) (21-01-2014)“…Pulmonary arterial hypertension (PAH) remains a concern in patients with β-thalassemia major (TM) and intermedia (TI); however, studies evaluating its…”
Get full text
Journal Article -
6
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization
Published in Blood (31-03-2022)“…Pulmonary arterial hypertension (PAH) is a life-threatening complication of β-thalassemia, especially in untransfused patients with thalassemia intermedia…”
Get full text
Journal Article -
7
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited
Published in Internal and emergency medicine (01-04-2019)“…Heart disease remains a leading cause of morbidity and mortality in transfusion-dependent thalassemia (TDT), which can be attributed to several factors but…”
Get full text
Journal Article -
8
Guideline recommendations for heart complications in thalassemia major
Published in Journal of cardiovascular medicine (Hagerstown, Md.) (01-05-2008)“…Thalassemia major is an inherited hemoglobin disorder resulting in a chronic hemolytic anemia. Transfusion therapy together with elevated gastrointestinal…”
Get full text
Journal Article -
9
Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy
Published in The American journal of cardiology (01-12-1992)“…The most typical physiopathologic abnormality in hypertrophie cardiomyopathy (HC) is diastolic dysfunction, characterized by abnormal stiffness of the left…”
Get full text
Journal Article -
10
Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization
Published in Blood (16-11-2012)“…Abstract 3262 Pulmonary artery hypertension (PAH) is a serious complication associated with considerable morbidity and mortality. The prevalence of PAH in…”
Get full text
Journal Article -
11
Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies
Published in Haematologica (Roma) (01-04-2005)“…Struttura Complessa di Cardiologia, Ospedali Galliera, Genoa, Italy. giorgio.egildo.derchi@galliera.it BACKGROUND AND OBJECTIVES: During the last decade new…”
Get full text
Journal Article -
12
Iron overload‐related heart failure in a patient with transfusion‐dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
Published in Clinical case reports (01-11-2015)“…Key Clinical Message Patients with transfusion‐dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia…”
Get full text
Journal Article -
13
Therapeutic Approaches to Pulmonary Hypertension in Hemoglobinopathies: Efficacy and Safety of Sildenafil in the Treatment of Severe Pulmonary Hypertension in Patients with Hemoglobinopathy
Published in Annals of the New York Academy of Sciences (01-11-2005)“…: New approaches to the treatment of pulmonary arterial hypertension (PH) have increased symptomatic relief and prolonged survival. PH is a common sequela of…”
Get full text
Journal Article -
14
Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension
Published in Blood (15-08-2002)Get full text
Journal Article -
15
Prevalence, Clinical and Instrumental Correlates of Myocardial Fibrosis and Necrosis by Delayed Contrast Enhancement Cardiovascular Magnetic Resonace in Thalassemia Major Patients
Published in Blood (16-11-2008)“…Cardiovascular Magnetic Resonance (CMR) by delayed enhancement (DE) has proven to visualize myocardial scarring, but no dedicated studies are available in…”
Get full text
Journal Article -
16
Human Immunodeficiency Virus and β-thalassemia Major: A "Competition of Guilt" for Pulmonary Arterial Hypertension. Report of A Case and A Review of the Literature
Published in Hemoglobin (01-01-2010)“…We report a case of a 43-year-old woman, affected by human immunodeficiency virus (HIV) and β-thalassemia major (β-TM), adequately treated with antiretroviral…”
Get full text
Journal Article -
17
Cardiovascular Involvement in Thalassemia Major Patients: WEB-THAL® Data Analysis (A Web-Based Multicentric Database)
Published in Blood (16-11-2007)“…Prevalence of Left Ventricular Dysfunction (LVD), and Congestive Heart Failure (CHF) have been widely described in Thalassemia Major (TM) patients (pts),…”
Get full text
Journal Article -
18
-
19
Standardized T2 Map of a Normal Human Heart to Correct T2 Segmental Artefacts; Myocardial Iron Overload and Fibrosis in Thalassemia Intermedia Versus Thalassemia Major Patients and Electrocardiogram Changes in Thalassemia Major Patients
Published in Hemoglobin (2008)“…Studies of the standardized, 3D, 16-segments map of the circumferential distribution of T2* values, of cardiovascular magnetic resonance (CMR) in thalassemia…”
Get full text
Journal Article -
20
Incidence of Pulmonary Hypertension in Haemoglobinopathic Patients without Left Ventricular Disfunction
Published in Blood (16-11-2005)“…Incidence of Pulmonary Hypertension (PH) has been described in haemoglobinopathic patients, ranging from 10% to 50%, depending on age, therapy, coexisting left…”
Get full text
Journal Article